Publication
Title
SGLT2 inhibitors and GLP-1 receptor agonists : a sound combination
Author
Abstract
Management of type 2 diabetes has evolved from a glucocentric to a holistic and patient-oriented approach. The focus now is not only on lowering HbA1c concentration without hypoglycaemia and bodyweight gain but also on reducing cardiovascular and renal morbidity and mortality.1 An ideal combination of antidiabetes drugs should have complementary effects that correct the many pathophysiological effects of type 2 diabetes and be safe, durable, well tolerated, easy to administer, and cost-effective.
Language
English
Source (journal)
Lancet diabetes & endocrinology. - Amsterdam
Publication
New york : Elsevier science inc, 2018
ISSN
2213-8587
Volume/pages
6:5(2018), p. 349-352
ISI
000430631600003
Full text (Publisher's DOI)
Full text (publisher's version - intranet only)
UAntwerpen
Faculty/Department
Research group
Publication type
Subject
Affiliation
Publications with a UAntwerp address
External links
Web of Science
Record
Identification
Creation 29.03.2018
Last edited 03.09.2021
To cite this reference